Xu lab:Publications: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
(30 intermediate revisions by 2 users not shown)
Line 9: Line 9:
'''Peer-reviewed Articles'''
'''Peer-reviewed Articles'''


26. Cheng, B., He, H., Zhang, J., and '''Xu, P.*''' Photothermal Stable Dual Responsive Gold/Mesoporous Silica Hybrid Nanoparticle as a Theranostic Platform for Cancer Therapy. (submitted)
29. Markoutsa, E. and '''Xu, P.*''' Redox Potential-Sensitive N‑Acetyl Cysteine-Prodrug Nanoparticles Inhibit the Activation of Microglia and Improve Neuronal Survival. ''Molecular Pharmaceutics'' (2017), 14 (5), 1591–1600 [http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b01028].


[[Image:Xu_lab_NAC-NP.gif|120px x 125px |NAC-NP]]
28. Patel, Y., Shah, N., Lee, JS., Markoutsa, E., Jie, C., Liu, S., Botbyl, R., Reisman, D., '''Xu, P.''', and Chen, H. A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.''Oncotarget'' (2016) 7, 18295-18308 [http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=7577&path%5B%5D=21903]
27. He, H., Altomare, D., Ozer, U., Xu, H., Creek, K., Chen, H., and '''Xu, P.*''' Cancer cell selective-killing polymer/copper combination. ''Biomaterials Science'' (2016), 4, 115 - 120. ('''Back Cover''') [http://pubs.rsc.org/en/content/articlelanding/2016/bm/c5bm00325c#!divAbstract].
[[Image:Xu_lab_cancer cell selective.tif|120px x 125px |CCS]]
26. Cheng, B., He, H., Huang, T., Berr, S., He, J., Fan D., Zhang, J., and '''Xu, P.*''' Gold Nanosphere Gated Mesoporous Silica Nanoparticle Responsive to NIR Light and Redox Potential as a Theranostic Platform for Cancer Therapy. ''Journal of Biomedical Nanotechnology'' (2016), 12, 435-449.[http://www.aspbs.com/JBN/contents_jbn2016123.htm]
[[Image:Xu_lab_GoMe.jpg|120px x 125px |GoMe]]


25. Cheng, B., Thapa, B., K.C., R., and '''Xu, P.*''' Dual secured nano-melittin for safe and effective eradicating cancer cells. ''Journal of Materials Chemistry B'' (2015), 3 (1), 25 - 29.
25. Cheng, B., Thapa, B., K.C., R., and '''Xu, P.*''' Dual secured nano-melittin for safe and effective eradicating cancer cells. ''Journal of Materials Chemistry B'' (2015), 3 (1), 25 - 29.
Line 119: Line 130:
'''Patents'''
'''Patents'''


11.   Radosz M., '''Xu, P., ''' and Shen, Y., Nanoparticles for cytoplasmic drug delivery to cancer cells. US Utility Patent application No. 11/662,514, issued patent No. 8,945,629. (02/03/2015)  
11. Yeo, Y., Bajaj, G., '''Xu, P.''',  Cho, E., and Liu, K. Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles. US Utility patent application No. 13/628,991, issued patent No. 9,393,262. (07/19/2016).
 
 
10. '''Xu, P.,''' and He, H. Preparation of Triple Responsive Nanogel System and its Application. US Utility patent application No.14/330,336, issued patent No. 9,283,281. (02/24/2016).
 
 
9. '''Xu, P.,''' and He, H. Polymeric prodrug of disulfiram and application thereof. US Utility patent application No. 14,962,426 (12/08/2015)




10. '''Xu, P.,''' and He, H. Polymer/copper combination for cancer targeted therapy. US Provisional patent application (10/21/2014)
8. '''Xu, P.,''' and K.C., R. Tetrary gene delivery system for gene therapy and methods of its use. US Utility patent application No.13/477,701, issued patent No. 9,168,230. (10/27/2015).




9. '''Xu, P.,''' Cheng, B., and He, H. PREPARATION OF GOLD NANOSPHERE/MESOPOROUS SILICA HYBRID NANOPARTICLE AND ITS APPLICATIONS. US Provisional patent application No. 62/070,580. (8/29/2014)
7. '''Xu, P.,''' and He, H. Polymer/copper combination for cancer targeted therapy. US Utility Patent application No. 14,887,373. (10/20/2015)




8. '''Xu, P.,''' and He, H. Preparation of Triple Responsive Nanogel System and its Application. US Utility patent application No.14/330,336.
6. '''Xu, P.,''' and K.C., B. Preparation of nanogel cocktail and its application. US Utility patent application No. 13/929,981, issued patent No. 9,149,535. (10/06/2015).




7. '''Xu, P.,''' and He, H. Preparation of D-Penicillamine Loaded Nanoparticle and Its Application. US Provisional patent application No. 61/911,120.
5. Shen, Y., and '''Xu, P., ''' Charge reversible polymers. PCT/US2007/015447. US Utility patent application No. 12/242,191, issued patent No. 9,145,472. (09/29/2015).




4. '''Xu, P.,''' Cheng, B., and He, H. Preparation of gold nanosphere/mesoporous silica hybrid nanoparticle and its application. US Utility patent application No. 14/833,711. (8/24/2015)


6.  '''Xu, P.,''' and K.C., B. Preparation of nanogel cocktail and its application. US Utility patent application No. 13/929,981.


3.  Radosz M., '''Xu, P., ''' and Shen, Y., Nanoparticles for cytoplasmic drug delivery to cancer cells.  US Utility Patent application No. 11/662,514, issued patent No. 8,945,629. (02/03/2015)


5.  '''Xu, P.,'''  Thapa, B., and Cheng, B. Dual secured therapeutic peptide delivery system for cancer therapy. US Utility Patent application No. 13/610,109, issued patent No. 8,809,277. (08/19/2014)


2. '''Xu, P.,''' Thapa, B., and Cheng, B. Dual secured therapeutic peptide delivery system for cancer therapy. US Utility Patent application No. 13/610,109, issued patent No. 8,809,277. (08/19/2014)
4.   '''Xu, P.,''' and K.C., R. Tetrary gene delivery system for safe and efficient gene therapy. US Utility patent application No.13/477,701




3.   Yeo, Y., '''Xu, P.''', Bajaj, G., Cho, E., and Liu, K. CHITOSAN DERIVATIVES FOR INACTIVATION OF ENDOTOXINS AND SURFACE PROTECTION OF NANOPARTICLES. US Utility patent application No. 13/628,991
1. Shen, Y., and '''Xu, P.''' Targeted charge-reversal nanoparticles for nuclear drug delivery. PCT/US2007/008146.




2.  Shen, Y., and '''Xu, P.,  ''' Charge reversible polymers. PCT/US2007/015447.


'''Book Chapter'''


1.  Shen, Y., and '''Xu, P.,  ''' Targeted charge-reversal nanoparticles for nuclear drug delivery. PCT/US2007/008146.


   
3. Cheng, B., and '''Xu, P.*''' Fabrication of Photothermal Stable Gold Nanosphere/Mesoporous Silica Hybrid Nanoparticle Responsive to Near-Infrared Light.  Reema Zeineldin. (eds). Cancer Nanotechnology. 2017, Volume 1530 of the series Methods in Molecular Biology.  pp 117-123, Springer New York. DOI: 10.1007/978-1-4939-6646-2_7.


2. He, H., Cheng, B., and '''Xu, P.*''' Natural Cationic Polymers for Gene Delivery.  In Merkel, O.M. and Amiji, M.M. (eds). Advances and Challenges in the Delivery of Nucleic Acid Therapeutics. 2015, Volume (1), pp 82-94, Future Science Ltd, London, UK. DOI: 10.4155/fseb2013.13.132.


1. He, H., K.C., R., '''Xu, P.*''' Fabrication of cRGD-Conjugated Dual-Responsive Micelles to Target αvβ5 Integrin-Overexpressed Cancer. Methods in Pharmacology and Toxicology, 2015, pp1-16, Humana Press. DOI: 10.1007/7653_2015_42.
   
   


'''ABSTRACTS AND PRESENTATIONS'''
'''ABSTRACTS AND PRESENTATIONS'''

Revision as of 14:47, 1 May 2017

PUBLICATIONS

Peer-reviewed Articles

29. Markoutsa, E. and Xu, P.* Redox Potential-Sensitive N‑Acetyl Cysteine-Prodrug Nanoparticles Inhibit the Activation of Microglia and Improve Neuronal Survival. Molecular Pharmaceutics (2017), 14 (5), 1591–1600 [1].

NAC-NP

28. Patel, Y., Shah, N., Lee, JS., Markoutsa, E., Jie, C., Liu, S., Botbyl, R., Reisman, D., Xu, P., and Chen, H. A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.Oncotarget (2016) 7, 18295-18308 [2]

27. He, H., Altomare, D., Ozer, U., Xu, H., Creek, K., Chen, H., and Xu, P.* Cancer cell selective-killing polymer/copper combination. Biomaterials Science (2016), 4, 115 - 120. (Back Cover) [3].

CCS

26. Cheng, B., He, H., Huang, T., Berr, S., He, J., Fan D., Zhang, J., and Xu, P.* Gold Nanosphere Gated Mesoporous Silica Nanoparticle Responsive to NIR Light and Redox Potential as a Theranostic Platform for Cancer Therapy. Journal of Biomedical Nanotechnology (2016), 12, 435-449.[4]

GoMe

25. Cheng, B., Thapa, B., K.C., R., and Xu, P.* Dual secured nano-melittin for safe and effective eradicating cancer cells. Journal of Materials Chemistry B (2015), 3 (1), 25 - 29. [5]. DSNS

24. He, H., Cattran, A., Nguyen, T., Nieminen, A., and Xu, P.* Triple-responsive Expansile Nanogel for Tumor and Mitochondria Targeted Photosensitizer Delivery. Biomaterials, (2014), 35, 9546–9553. [6]

TRN


23. K.C., R., Chandrashekaran, V., Cheng, B., Chen, H., Peña, M., Zhang, J., Montgomery, J., Xu, P.* Redox Potential Ultrasensitive Nanoparticle for Targeted Camptothecin Delivery to HER2-Positive Cancer Cells. Molecular Pharmaceutics, (2014), 11, 1897−1905. [7]

HCN


22. Chen, Y., Wu, C., Yeo, Y., Xu, P., Lin, T. A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge. Veterinary Immunology and Immunopathology (2013), 152: 359-369. [8]

21. Cao, Z., Chen, F., Bao, N., He, H., Xu, P., Jana, S., Jung, S., Lian, H., Lu, C. Droplet Sorting Based on the Number of Encapsulated Particles Using a Solenoid Valve. Lab on a Chip, (2013),13, 171-178. [9]


20. K.C. R., Xu P.*, Multicompartment Intracellular Self-expanding Nanogel for Targeted Delivery of Drug Cocktail. Advanced Materials, (2012),24(48): 6479-6483. [10] Highlighted as a key scientific article in Global Medical Discovery [11] Reported by Science Daily [12] Drug Discovery Today [13] Azonano [14] Genesis Nanotech [15] Polymer solutions [16], and Newswise [17]

NCPD 


19. K.C. R., Thapa B., Xu P.*, pH and redox dual responsive nanoparticle for nuclear targeted drug delivery. Molecular Pharmaceutics, (2012) 9 (9), 2719-2729. (One of the journal’s Top 10 most read articles during July-September 2012) [18]

PDA-DOX


18. K.C. R., Thapa B., Xu P.*, Design of serum compatible tetrary complexes for gene delivery. Macromol. Biosci. (2012), 12, 637–646. (Cover page) [19]

PoSC MB Cover 

PoSC_cover_ftp.pdf.


17. Chen F, Zhan Y, Geng T, Lian H, Xu P, Lu C. Chemical Transfection of Cells in Picoliter Aqueous Droplets in Fluorocarbon Oil. Anal Chem. (2011), 83 (22), 8816–8820. [20]


16. Shen, Y., Zhou, Z., Sui, M., Tang, J., Xu, P., Van Kirk, E.A., Murdoch, W.J., Fan, M., and Radosz, M. Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery. Nanomedicine, (2010), 5(8), 1205-1217. [21]


15. Xu, P., Bajaj, G., Shugg, T., Van Alstine, W., and Yeo, Y.: Zwitterionic chitosan derivatives for pH-sensitive stealth coating. Biomacromolecules. (2010), 11(9), 2352-2358. [22]


14. Ma H., Jones K.R., Guo R., Xu, P., Shen Y., and Ren J., Cisplatin Compromises Myocardial Contractile Function and Mitochondrial Ultrastructure: Role of Endoplasmic Reticulum Stress. Clin Exp Pharmacol Physiol. (2010), 37(4), 460-465.


13. Xu, P., Quick G. and Yeo, Y., Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine. Biomaterials. (2009), 30 (29):5834-43.


12. Ma, H., Li, S., Xu, P., Babcock, S.A., Dolence, E.K., Brownlee, M., Li, J., and Ren, J., Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) upregulation contribute to the onset of diabetic cardiomyopathy. Journal of Cellular and Molecular Medicine (2009), 13(8b), 1751-64.


11. Xu, P., Gullotti, E., Tong, L., Highley, C.B., Errabelli, D.R., Hasan, T., Cheng, J., Kohane, D.S., and Yeo, Y., Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Molecular Pharmaceutics (2009), 6(1), 190-201.


10. Yang, Y., Bajaj, N., Xu, P., Ohn, K., Tsifansky, M., and Yeo, Y. Development of highly porous large PLGA microparticles for sustained local drug delivery to the lung. Biomaterials (2009), 30(10), 1947-53.


9. Xu, P., Li, S., Li, Q., Van Kirk, E.A, Ren, J., Murdoch, W.J., Zhang, Z., Radosz, M., and Shen, Y. Virion-mimicking nanocapsules from pH-controlled hierarchical self-assembly for gene delivery. Angew Chem Int Ed. (2008), 47(7), 1260-1264.


8. Shen, Y., Zhan Y., Tang J., Xu P., Johnson P.A., Radosz M., Van Kirk E.A., Murdoch, W.J. Multifunctioning pH-responsive nanoparticles from hierarchical self-assembly of polymer brush for cancer drug delivery. AIChE Journal (2008), 54 (11), 2979-2989.


7. Turdi, S., Xu, P., Li, Q., Kerram, P., Shen, Y., and Ren, J., Amidization of doxorubicin alleviates doxorubicininduced cardiomyopathy. Toxicol. Lett. (2008), 178(3), 197-201


6. Xu, P., Van, Kirk E.A., Zhan, Y., Murdoch, W.J., Radosz, M., and Shen, Y., Targeted charge-reversal nanoparticles for nuclear drug delivery. Angew Chem Int Ed. (2007), 46(26), 4999-5002.


5. Jin, W., Xu, P., Zhan, Y., Shen, Y., Van Kirk, E.A., Alexander, B., Murdoch, W.J., Liu, L., and Issak, D.D., Degradable cisplatin-releasing core-shell nanogels from zwitterionic poly(beta-aminoester)-graft-PEG for cancer chemotherapy. Drug Delivery. (2007), 14(5), 279-86.


4. Xu, P., Li, S., Li, Q., Ren, J., Van Kirk, E.A., Murdoch, W.J., Radosz, M., and Shen, Y., Biodegradable cationic polyester as an efficient carrier for gene delivery to neonatal cardiomyocytes. Biotechnology & Bioengineering (2006), 95(5), 893-903.


3. Xu, P., Van Kirk, Edward E.A., Murdoch, W.J., Zhan, Y., Isaak, Dale D., Radosz, M., and Shen, Y., Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles. Biomacromolecules (2006), 7(3), 829-835.


2. Xu, P., Van Kirk, E.A., Li, S., Murdoch, W.J., Ren, J., Hussain, M.D., Radosz, M., and Shen, Y., Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloids and Surfaces, B: Biointerfaces (2006), 48(1), 50-57.


1. Xu, P., Tang, H., Li, S., Ren, J., Van Kirk, E.A., Murdoch, W.J., Radosz, M., and Shen, Y., Enhanced stability of core-surface cross-linked micelles fabricated from amphiphilic brush copolymers. Biomacromolecules (2004), 5(5), 1736-1744.


Patents

11. Yeo, Y., Bajaj, G., Xu, P., Cho, E., and Liu, K. Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles. US Utility patent application No. 13/628,991, issued patent No. 9,393,262. (07/19/2016).


10. Xu, P., and He, H. Preparation of Triple Responsive Nanogel System and its Application. US Utility patent application No.14/330,336, issued patent No. 9,283,281. (02/24/2016).


9. Xu, P., and He, H. Polymeric prodrug of disulfiram and application thereof. US Utility patent application No. 14,962,426 (12/08/2015)


8. Xu, P., and K.C., R. Tetrary gene delivery system for gene therapy and methods of its use. US Utility patent application No.13/477,701, issued patent No. 9,168,230. (10/27/2015).


7. Xu, P., and He, H. Polymer/copper combination for cancer targeted therapy. US Utility Patent application No. 14,887,373. (10/20/2015)


6. Xu, P., and K.C., B. Preparation of nanogel cocktail and its application. US Utility patent application No. 13/929,981, issued patent No. 9,149,535. (10/06/2015).


5. Shen, Y., and Xu, P., Charge reversible polymers. PCT/US2007/015447. US Utility patent application No. 12/242,191, issued patent No. 9,145,472. (09/29/2015).


4. Xu, P., Cheng, B., and He, H. Preparation of gold nanosphere/mesoporous silica hybrid nanoparticle and its application. US Utility patent application No. 14/833,711. (8/24/2015)


3. Radosz M., Xu, P., and Shen, Y., Nanoparticles for cytoplasmic drug delivery to cancer cells. US Utility Patent application No. 11/662,514, issued patent No. 8,945,629. (02/03/2015)


2. Xu, P., Thapa, B., and Cheng, B. Dual secured therapeutic peptide delivery system for cancer therapy. US Utility Patent application No. 13/610,109, issued patent No. 8,809,277. (08/19/2014)


1. Shen, Y., and Xu, P., Targeted charge-reversal nanoparticles for nuclear drug delivery. PCT/US2007/008146.


Book Chapter


3. Cheng, B., and Xu, P.* Fabrication of Photothermal Stable Gold Nanosphere/Mesoporous Silica Hybrid Nanoparticle Responsive to Near-Infrared Light. Reema Zeineldin. (eds). Cancer Nanotechnology. 2017, Volume 1530 of the series Methods in Molecular Biology. pp 117-123, Springer New York. DOI: 10.1007/978-1-4939-6646-2_7.

2. He, H., Cheng, B., and Xu, P.* Natural Cationic Polymers for Gene Delivery. In Merkel, O.M. and Amiji, M.M. (eds). Advances and Challenges in the Delivery of Nucleic Acid Therapeutics. 2015, Volume (1), pp 82-94, Future Science Ltd, London, UK. DOI: 10.4155/fseb2013.13.132.

1. He, H., K.C., R., Xu, P.* Fabrication of cRGD-Conjugated Dual-Responsive Micelles to Target αvβ5 Integrin-Overexpressed Cancer. Methods in Pharmacology and Toxicology, 2015, pp1-16, Humana Press. DOI: 10.1007/7653_2015_42.


ABSTRACTS AND PRESENTATIONS


16. Xu. P., Yeo, Y., Polyanion-Coated Intracellularly Degradable Nanoparticles as a Safe and Efficient Gene Delivery System. 35th Annual Meeting of the Controlled Release Society, New York, NY, (2008)


15. Yeo, Y., Yang, Y., Bajaj, N., Xu, P., Development of Highly Porous PLGA Microparticles for Sustained Local Drug Delivery to the Lung. 35th Annual Meeting of the Controlled Release Society, New York, NY, (2008)


14. Ma, H., Xu, P., Shen, Y., Ren, J., Cisplatin compromises the ultrastructure of mitochondria and mechanical func tion of cardiomyocytes. 2008 NISBRE, Washington DC, (2008)


13. Xu, P., Van Kirk, E.A., Zhan, Y., Murdoch, W.J., Radosz, M., and Shen, Y., Targeted charge-reversal nanoparticles for nuclear drug delivery. 34th Annual Meeting of the Controlled Release Society, Long Beach, California, (2007)


12. Xu, P., Zhan, Y., Van Kirk, E.A., Murdoch, W.J., and Shen, Y., Charge-reversal PAMAM dendrimer. 34th Annual Meeting of the Controlled Release Society, Long Beach, California, (2007).


11. Xu, P., Zhan, Y., Li, S., Van Kirk, E.A., Ren, J., Murdoch, W.J., Radosz, M., and Shen, Y., Artificial virion nanocapsules for gene delivery. 34th Annual Meeting of the Controlled Release Society, Long Beach, California, (2007).


10. Xu, P., Zhan, Y., Li, S., Van Kirk, E.A., Ren, J., Murdoch, W.J., Radosz, M., and Shen, Y., Layered nanoparticles for gene delivery. 232nd ACS National Meeting, San Francisco (2006).


9. Xu, P., Li, S., Li, Q., Zhan, Y., Ren, J., Radosz, M., and Shen, Y., Polymeric artificial virus for gene delivery. 231st ACS National Meeting, Atlanta (2006).


8. Zhan, Y., Van Kirk, E.A., Xu, P., Murdoch, W.J., Radosz, M., and Shen, Y., pH-responsive three layer onion-structured nanoparticles for drug delivery. 231st ACS National Meeting, Atlanta (2006).


7.Xu P., Li S., Li Q., Ren J., Shen Y., and Radosz M., Modified polymers as safe and efficient gene delivery carriers. 230th ACS National Meeting, Washington (2005).


6.Shen, Y., Xu, P., Li, S., Li, Q., Ren, J., Van Kirk, E.A., Murdoch, W.J., and Radosz, M., Biodegradable cationic polymers as efficient gene delivery carriers. 229th ACS National Meeting, San Diego (2005).


5.Xu, P., Tang, H., Li, S., Ren, J., Van Kirk, E.A., Murdoch, W.J., Radosz, M., and Shen, Y., Highly stable core-surface-crosslinked micelles as drug carriers for cancer chemotherapy. AIChE Annual Meeting, Austin (2004)


4.Xu, P., Van Kirk, E.A., Li, S., Ren, J., Murdoch, W.J., Radosz, M., and Shen, Y. Enhanced anticancer activity of core-surface-crosslinked nanoparticles. 228th ACS National Meeting, Philadelphia (2004).


3.Xu, P., Radosz, M., and Shen, Y., Pseudo "living" free radical copolymerization of methacrylic macromonomers. 228th ACS National Meeting, Philadelphia (2004).


2.Yang, X., Xu, P., Ding, S., Radosz, M., Shen, Y., Synthesis of 1-(4-vinylbenzyl)thymine and its polymerization by RAFT and ATRP techniques. 227th ACS National Meeting, Anaheim (2004).


1.Xu, P., Radosz, M., and Shen, Y., Core-surface crosslinked micelles fabricated from PCL/PEG brush copolymers. 227th ACS National Meeting, Anaheim (2004).